Pay in 4 interest-free payments of $30.00 Learn more
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6
(S)-Thalidomide treatment increased apoptosis in a dose-dependent manner in U266 cells
It is approved for the treatment of benign prostatic hyperplasia (BPH) and is prescibed off-label for the treatment of male pattern baldness (MPB)
Inhibits locomotor activity in mice expressing hM3Dq and hM4Di in D1-expressing neurons
They inhibited the growth of Gram-positive bacteria and fungi
indicating the amnesic action of scopolamine
Fluorescein-PEG5-NHS ester Size:Contact [email protected] for quotation (S)-Thalidomide treatment increased apoptosis inFluorescein PEG5 NHS ester is a PEG based PROTAC linker that can be used in the synthesis of PROTACs. Product information CAS Number: 2353409 62 6 Molecular Weight: 795. 81 Formula: C38H41N3O14S Chemical Name: 2,5 dioxopyrrolidin 1 yl 1 [({3',6' dihydroxy 3 oxo 3H spiro[2 benzofuran 1,9' xanthen] 5 yl}carbamothioyl)amino] 3,6,9,12,15 pentaoxaoctadecan 18 oate Smiles: